Cover Image
市場調查報告書

睡眠呼吸中止症:全球臨床實驗趨勢

Sleep Apnea Global Clinical Trials Review, H1, 2016

出版商 GlobalData 商品編碼 169706
出版日期 內容資訊 英文 169 Pages
訂單完成後即時交付
價格
Back to Top
睡眠呼吸中止症:全球臨床實驗趨勢 Sleep Apnea Global Clinical Trials Review, H1, 2016
出版日期: 2016年02月29日 內容資訊: 英文 169 Pages
簡介

睡眠呼吸中止症是最常見的無呼吸症狀,特徵是在睡眠時呼吸減少或是暫時停止呼吸。共有中樞性睡眠呼吸中止症(CSA),阻塞型睡眠呼吸中止症(OSA),混合性睡眠呼吸中止症(CSA和OSA混合)等3種類型。

本報告提供睡眠呼吸中止症臨床實驗相關之最新趨勢分析,提供您各地區的臨床實驗數量,臨床實驗的各階段進展,受驗對象採用狀況,有潛力的贊助商,各企業和研究機關的研究進展,有潛力的藥劑比較等資訊。

簡介

  • 睡眠呼吸中止症
  • 本報告概要

各地區的臨床實驗情形

  • 各國臨床實驗數量和平均實驗人數
    • 亞太地區主要5國的臨床實驗數量
    • 歐洲主要5國的臨床實驗數量
    • 北美主要國家的臨床實驗數量
    • 中東·非洲主要國家的臨床實驗數量
    • 中南美主要國家的臨床實驗數量

G7各國臨床實驗數量:心臟疾病治療藥臨床實驗上睡眠呼吸中止症的比例

G7各國的各階段臨床實驗數量

G7各國臨床實驗數量:各進展狀況

E7各國臨床實驗數量:心臟疾病治療藥臨床實驗上睡眠呼吸中止症的比例

E7各國的各階段臨床實驗數量

各階段臨床實驗數量

  • 進行中的臨床實驗:各階段

各進展狀況臨床實驗數量

臨床實驗的目標的達成情形

未完成的臨床實驗數量

一定期間所採用的受驗對象

贊助商類別的臨床實驗數量

有潛力的贊助商

  • 睡眠呼吸中止症臨床實驗主要的參與企業

有潛力的藥劑

臨床實驗簡介

  • 主要企業臨床實驗概要
    • Cephalon, Inc. (Inactive)
    • Merck & Co., Inc.
    • Jazz Pharmaceuticals Plc
    • Cortex Pharmaceuticals, Inc.
    • Sumitomo Dainippon Pharma Co., Ltd
    • Koninklijke Philips N.V.
    • Bioprojet SCR
    • Altasciences Company Inc
    • Alfresa Holdings Corporation
    • Abbott Laboratories
  • 有代表性的研究機關·醫院臨床實驗概要
    • Brigham and Women's Hospital
    • Woolcock Institute of Medical Research
    • Associacao Fundo de Incentivo a Psicofarmcologia
    • U.S. Department of Veterans Affairs
    • University of Chicago
    • Chinese University of Hong Kong
    • Hospital do Servidor Publico Estadual
    • Karolinska University Hospital
    • University of Wisconsin Madison
    • University of Zurich

5個有代表性的臨床實驗簡介

附錄

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: GDHC3248CTIDB

GlobalData's clinical trial report, "Sleep Apnea Global Clinical Trials Review, H1, 2016" provides an overview of Sleep Apnea clinical trials scenario. This report provides top line data relating to the clinical trials on Sleep Apnea. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData's proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • The report provides a snapshot of the global clinical trials landscape
  • Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
  • The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
  • The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
  • The Report provides enrollment trends for the past five years
  • Report provides latest news for the past three months

Reasons to buy

  • Assists in formulating key business strategies with regards to investment
  • Helps in identifying prominent locations for conducting clinical trials which saves time and cost
  • Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
  • Supports understanding of trials count and enrollment trends by country in global therapeutics market
  • Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
  • Facilitates clinical trial assessment of the indication on a global, regional and country level

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • Report Guidance
  • Clinical Trials by Region
    • Clinical Trials and Average Enrollment by Country
      • Top Five Countries Contributing to Clinical Trials in Asia-Pacific
      • Top Five Countries Contributing to Clinical Trials in Europe
      • Top Countries Contributing to Clinical Trials in North America
      • Top Five Countries Contributing to Clinical Trials in Middle East and Africa
      • Top Countries Contributing to Clinical Trials in Central and South America
  • Clinical Trials by G7 Countries: Proportion of Sleep Apnea to Respiratory Clinical Trials
  • Clinical Trials by Phase in G7 Countries
  • Clinical Trials in G7 Countries by Trial Status
  • Clinical Trials by E7 Countries: Proportion of Sleep Apnea to Respiratory Clinical Trials
  • Clinical Trials by Phase in E7 Countries
  • Clinical Trials in E7 Countries by Trial Status
  • Clinical Trials by Phase
    • In Progress Trials by Phase
  • Clinical Trials by Trial Status
  • Clinical Trials by End Point Status
  • Subjects Recruited Over a Period of Time
  • Clinical Trials by Sponsor Type
  • Prominent Sponsors
    • Top Companies Participating in Sleep Apnea Therapeutics Clinical Trials
  • Prominent Drugs
  • Clinical Trial Profile Snapshots
  • Appendix
    • Abbreviations
    • Definitions
    • Research Methodology
    • Secondary Research
    • About GlobalData
    • Contact Us
    • Disclaimer
    • Source

List of Tables

  • Sleep Apnea Therapeutics, Global, Clinical Trials by Region, 2016*
  • Sleep Apnea Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2016*
  • Sleep Apnea Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2016*
  • Sleep Apnea Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2016*
  • Sleep Apnea Therapeutics Clinical Trials, Europe, Top Five Countries, 2016*
  • Sleep Apnea Therapeutics Clinical Trials, North America, Top Countries, 2016*
  • Sleep Apnea Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2016*
  • Sleep Apnea Therapeutics Clinical Trials, Central and South America, Top Countries, 2016*
  • Proportion of Sleep Apnea to Respiratory Clinical Trials, G7 Countries (%), 2016*
  • Sleep Apnea Therapeutics, G7 Countries, Clinical Trials by Phase, 2016*
  • Sleep Apnea Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2016*
  • Proportion of Sleep Apnea to Respiratory Clinical Trials, E7 Countries (%), 2016*
  • Sleep Apnea Therapeutics, E7 Countries, Clinical Trials by Phase, 2016*
  • Sleep Apnea Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2016*
  • Sleep Apnea Therapeutics, Global, Clinical Trials by Phase, 2016*
  • Sleep Apnea Therapeutics, Global, Clinical Trials In Progress by Phase 2016*
  • Sleep Apnea Therapeutics, Global, Clinical Trials by Trial Status, 2016*
  • Sleep Apnea Therapeutics Clinical Trials, Global, by End Point Status, 2016*
  • Sleep Apnea Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2011-2015
  • Sleep Apnea Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2016*
  • Sleep Apnea Therapeutics Clinical Trials, Global, Key Sponsors, 2016*
  • Sleep Apnea Therapeutics Clinical Trials, Global, Top Companies by Phase, 2016*
  • Sleep Apnea Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2016*

List of Figures

  • Sleep Apnea Therapeutics, Global, Clinical Trials by Region (%), 2016*
  • Sleep Apnea Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2016*
  • Sleep Apnea Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2016*
  • Sleep Apnea Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2016*
  • Sleep Apnea Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2016*
  • Sleep Apnea Therapeutics Clinical Trials, North America, Top Countries (%), 2016*
  • Sleep Apnea Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 2016*
  • Proportion of Sleep Apnea to Respiratory Clinical Trials, G7 Countries (%), 2016*
  • Sleep Apnea Therapeutics, G7 Countries, Clinical Trials by Phase, 2016*
  • Sleep Apnea Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2016*
  • Proportion of Sleep Apnea to Respiratory Clinical Trials, E7 Countries (%), 2016*
  • Sleep Apnea Therapeutics, E7 Countries, Clinical Trials by Phase, 2016*
  • Sleep Apnea Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2016*
  • Sleep Apnea Therapeutics, Global, Clinical Trials by Phase (%), 2016*
  • Sleep Apnea Therapeutics, Global, Clinical Trials In Progress by Phase, 2016*
  • Sleep Apnea Therapeutics, Global, Clinical Trials by Trial Status, 2016*
  • Sleep Apnea Therapeutics Clinical Trials, Global, by End Point Status, 2016*
  • Sleep Apnea Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2011-2015
  • Sleep Apnea Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2016*
  • Sleep Apnea Therapeutics Clinical Trials, Global, Key Sponsors, 2016*
  • Sleep Apnea Therapeutics Clinical Trials, Global, Top Companies by Phase, 2016*
  • Sleep Apnea Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2016*
  • GlobalData Methodology
Back to Top